CEO, President, Chairman of Bd, 10% Owner of Pain Therapeutics (PTIE, Financial) Remi Barbier sells 50,000 shares of PTIE on 02/02/2010 at an average price of $5.32 a share.
Pain Therapeutics has a market cap of $228 million; its shares were traded at around $5.4 with and P/S ratio of 11.1.
PTIE is in the portfolios of Paul Tudor Jones of The Tudor Group.
Pain Therapeutics has a market cap of $228 million; its shares were traded at around $5.4 with and P/S ratio of 11.1.
PTIE is in the portfolios of Paul Tudor Jones of The Tudor Group.
CEO Recent Trades:
- Sell:: CEO, Chairman of Board, 10% Owner Remi Barbier sold 50,000 shares of PTIE stock on 01/06/2010 at the average price of 5.39, the price of the stock has increased by 0.19% since.
- Sell:: CEO,, 10% Owner Remi Barbier sold 50,000 shares of PTIE stock on 11/05/2009 at the average price of 4.83, the price of the stock has increased by 11.8% since.
- Sell:: CEO, 10% Owner Remi Barbier sold 20,000 shares of PTIE stock on 10/02/2009 at the average price of 5.1, the price of the stock has increased by 5.88% since.
- Sell:: CEO, 10% Owner Remi Barbier sold 23,200 shares of PTIE stock on 09/11/2009 at the average price of 5.23, the price of the stock has increased by 3.25% since.
CFO Recent Trades:
- Sell:: CFO Peter S Roddy sold 40,000 shares of PTIE stock on 08/31/2009 at the average price of 5.08, the price of the stock has increased by 6.3% since.
Directors and Officers Recent Trades:
- Sell:: COO Nadav Friedmann sold 15,000 shares of PTIE stock on 11/16/2009 at the average price of 5, the price of the stock has increased by 8% since.
- Sell:: 10% Owner Capital Management Eastbourne sold 3,076,915 shares of PTIE stock on 09/29/2009 at the average price of 4.98, the price of the stock has increased by 8.43% since.
